VIDEO | Amplia featured on Channel 9 NewsWe are pleased to share further top tier media coverage following the Garvan Institute of Medical Research’s release of a paper in Science Advances, which demonstrates that pre-treatment with a FAK inhibitor improves the effectiveness of chemotherapy in a preclinical model of pancreatic cancer. The news was covered by Channel 9 Health Reporter, Gabriella Rogers, as part of a 2+ minute feature story. Click here to watch. Posted on 30 Sep 2021 . Updated on 07 Oct 2021 by Amplia Therapeutics